Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placenta extract injection for androgenetic hair loss
IRCT20210612051545N5Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2022
- Modality
- Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of LAENNEC in androgenetic alopecia (AGA) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Side effects. Started Nov 2022; status: completed.
02
Drugs
LAENNEC
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20210612051545N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210612051545N5.